Should Drugmakers Pay FDA to Inspect Foreign Factories?

The drug industry may pony up so the FDA can inspect foreign manufacturing plants.
Three big trade groups (Pharmaceutical Research and Manufacturers of America, the Generic Pharmaceutical Association and the Biotechnology Industry Organization) yesterday told Congress they may be willing to pay new “user fees” so the FDA can beef up its overseas inspections, the Newark [...]